# Fludeoxyglucose F18

NDC: 62072-008
Generic name: Fludeoxyglucose F18
Labeler / Manufacturer: Kreitchman PET Center
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20160509

FDA application: ANDA203942

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 100 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62072-008"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62072-008
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e415eb3-e8a5-4149-b4ec-ba9ab3b29d7f